← Back to headlines
TD Cowen Cautious on Amicus Therapeutics Despite Positive Revenue Projections
TD Cowen maintains a cautious outlook on Amicus Therapeutics (FOLD) even with positive revenue projections for 2025.
19 Feb, 00:38 — 19 Feb, 00:38
ℹOnly 1 source covers this story
